View more on these topics

Keeping pace with medical advances

It would be reassuring to know that within the next 10 years we’ll be able to scan, screen or test for the most debilitating illnesses quickly, followed by swift, effective treatment. And when you look at the medical advances of the past couple of months it’s easy to believe that anything is possible.

US researchers have made the amazing discovery of enzymes that react abnormally on the skin of Alzheimer’s patients. The study indicates that a test could distinguish Alzheimer’s from other brain damaging diseases such as Parkinson’s. At the moment, Alzheimer’s can only be diagnosed using psychiatric assessment or during a post-mortem. This test would mean that patients could be diagnosed and hopefully treated before the distressing symptoms associated with the disease develop.

On a similarly positive note, a trial using blood tests to detect breast cancer at an earlier stage than is currently possible has been successful. It seems this test could be adapted to identify melanoma and detect prostate and ovarian cancers at a stage when people look and feel fine.

It makes sense to assume that these types of advances will bring more claims on critical illness policies at earlier stages of diseases. So is this likely to happen and, if it does, will a rise in claims for early stage illnesses result in increased premiums for critical illness cover?

The good news is that the Association of British Insurers’ critical illness definitions published in its statement of best practice earlier this year reflect possible advances of this nature.

As a result, the definitions of degenerative diseases such as Alzheimer’s provide cover from when symptoms start. Equally, the cancer definition covers tumours from the point of invasion and medical experts agree that the earlier the diagnosis, the better the prognosis. Early cancers that don’t respond to treatment become covered later. This means that no life-threatening cases should slip through the net.

The statement of best practice also brings greater clarity through more descriptive headings – for example, ‘cancer – excluding less ad-vanced cases’. And the definition further emphasises what is and is not covered by making it clear that conditions such as pre-malignant, non- invasive and cancers in situ are not covered.

This acknowledgment of the likely implications of medical advances will help ensure premiums are stabilised. Without this type of self-regulation the definitions and premiums may have had to be changed every time a medical breakthrough came along.

By having definitions that don’t have to change regularly, everyone should be clearer about what is and is not covered. This is good news, especially for consumers.

Recommended

Edeus hits 5,000 broker target early

Edeus has signed up its 5,000th intermediary. It reached the mark – its target for the end of this year – just 10 days after it launched online.

AVM market to treble, says Hometrack

The market for Automated Valuation Models is set to treble in the next two years as mortgage lending remains strong and lenders increase their uptake of online valuation services to streamline and improve the mortgage application process, predicts Hometrack.Hometrack has been at the forefront of this evolving market and continues to increase its lead in […]

Mortgage Next launches buy-to-let range

Mortgage Next has launched two three-year buy-to-let mortgages available exclusively via members of the Mortgage Next Network and directly authorised brokers registered with Mortgage Next Partners.The buy-to-let mortgages, which are funded by Mortgage Express, consists of a discount of 1.26% for three years giving an initial pay rate of 5.24% with a 1% completion fee, […]

SMS named top packager

Solent Mortgage Services has been named packager of the year by lending partner Preferred. This is the fourth time SMS has won this accolade.

Newsletter

News and expert analysis straight to your inbox

Sign up